Evidence map›Paper›PMID 18708408›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2008

Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.

Jane C Figueiredo, A Joan Levine, Maria V Grau, Oivind Midttun, Per M Ueland, Dennis J Ahnen, Elizabeth L Barry, Shirley Tsang, David Munroe, Iqbal Ali and 3 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk.Cancer prevention research (Philadelphia, Pa.) · 2017
    Trial
  2. Trial
  3. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2009
    Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2010
    Article
  17. Dairy consumption and patterns of mortality of Australian adults.European journal of clinical nutrition · 2010
    Article
  18. Article
  19. Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Jane C FigueiredoDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Harlyne J Norris Cancer Research Tower, 1450 Biggy Street Room 1509B, Los Angeles CA 90033, USA. janefigu@usc.edu
A Joan Levine
Maria V Grau
Oivind Midttun
Per M Ueland
Dennis J Ahnen
Elizabeth L Barry
Shirley Tsang
David Munroe
Iqbal Ali
Robert W Haile
Robert S Sandler
John A Baron
Dartmouth College · USUniversity of Southern California · USScience Applications International Corporation (United States) · USNational Cancer Institute · USUniversity of Bergen · NOUniversity of Colorado Denver · USUniversity of North Carolina at Chapel Hill · US

Funding

FOLATE, DNA METHYLATION AND CARCINOGENESIS IN THE BOWELR01CA059005 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARON, JOHN ANTHONY · 1993 to 2013
$17.3M
Folate, 1-Carbon Nutrients, Gene Variants &Colon CancerU54CA100971 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI HUNTER, DAVID JOHN · 2003 to 2008
$7.0M
NCI NIH HHS R01 CA059005NCI NIH HHS R01-CA-059005NCI NIH HHS U54 CA100971NCI NIH HHS U54-CA-100971
6 · The paper itself

Abstract

backgroundFolate, other vitamin B cofactors, and genes involved in folate-mediated one-carbon metabolism all may play important roles in colorectal neoplasia. In this study, we examined the associations between dietary and circulating plasma levels of vitamins B(2), B(6), and B(12) and risk colorectal adenomas.

methodsThe Aspirin/Folate Polyp Prevention Study is a randomized clinical trial of folic acid supplementation and incidence of new colorectal adenomas in individuals with a history of adenomas (n = 1,084). Diet and supplement use were ascertained through a food frequency questionnaire administered at baseline. Blood collected at baseline was used to determine plasma B-vitamin levels. We used generalized linear regression to estimate risk ratios (RR) and 95% confidence intervals (95% CI) as measures of association.

resultsWe found a borderline significant inverse association with plasma B(6) [pyridoxal 5'-phosphate (PLP)] and adenoma risk (adjusted RR Q4 versus Q1, 0.78; 95% CI, 0.61-1.00; P(trend) = 0.08). This association was not modified by folic acid supplementation or plasma folate. However, the protective association of PLP with adenoma risk was observed only among subjects who did not drink alcohol (P(interaction) = 0.03). Plasma B(2) (riboflavin) was inversely associated with risk of advanced lesions (adjusted RR Q4 versus Q1, 0.51; 95% CI, 0.26-0.99; P(trend) = 0.12). No significant associations were observed between adenoma risk and plasma vitamin B(12) or dietary intake of vitamin B(2) and B(6). When we examined specific gene-B-vitamin interactions, we observed a possible interaction between methylenetetrahydrofolate reductase -C677T and plasma B(2) on risk of all adenomas.

conclusionOur results suggest that high levels of PLP and B(2) may protect against colorectal adenomas.

Indexed as

AdenomaAlcohol DrinkingAspirinChemopreventionColorectal NeoplasmsDouble-Blind MethodFemaleFolic AcidGenotypeHumansIncidenceLinear ModelsMaleMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedNeoplasm Recurrence, LocalAspirinFolic AcidMethylenetetrahydrofolate Reductase (NADPH2)RiboflavinVitamin B 12Vitamin B 6

Identifiers

PMID18708408
PMCPMC2518404
OpenAlexW2125052066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.